Literature DB >> 3276268

Hepatic candidiasis in cancer patients: the evolving picture of the syndrome.

M Thaler1, B Pastakia, T H Shawker, T O'Leary, P A Pizzo.   

Abstract

Focal hepatosplenic candidiasis has been recognized with increasing frequency in recent years. We reviewed the cases of eight patients seen between 1982 and 1985, and information on 60 patients whose cases have been reported in the world literature. The characteristics of focal hepatosplenic candidiasis include persistent fever in a neutropenic patient whose leukocyte count is returning to normal, often coupled with abdominal pain; an elevated alkaline phosphatase level; and less commonly, rebound leukocytosis. The characteristic "bull's eye" lesions seen with hepatic ultrasound examination or computed tomography generally are not detectable until neutrophil recovery has occurred. Diagnosis can be established only by biopsy evidence of yeasts or pseudohyphae in the granulomatous lesions. Cultures are frequently negative, however, especially in patients who have been pretreated with antifungal agents. We review the evolving nature of hepatosplenic candidiasis, focusing on diagnosis and treatment.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3276268     DOI: 10.7326/0003-4819-108-1-88

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  63 in total

1.  Experimental gastrointestinal and disseminated candidiasis in immunocompromised animals.

Authors:  T J Walsh; P A Pizzo
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

2.  Successful treatment of focal hepatic candidiasis with liposomal amphotericin B.

Authors:  B O'Connell; G Crotty; M T Cafferkey; R Stephens; G S McDonald; S R McCann
Journal:  Ir J Med Sci       Date:  1992-12       Impact factor: 1.568

3.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

4.  High-throughput identification of clinical pathogenic fungi by hybridization to an oligonucleotide microarray.

Authors:  Aihua Huang; Jun-Wen Li; Zhi-Qiang Shen; Xin-Wei Wang; Min Jin
Journal:  J Clin Microbiol       Date:  2006-09       Impact factor: 5.948

5.  A nosocomial cluster of Candida inconspicua infections in patients with hematological malignancies.

Authors:  D D'Antonio; B Violante; A Mazzoni; T Bonfini; M A Capuani; F D'Aloia; A Iacone; F Schioppa; F Romano
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

6.  Detection and identification of fungal pathogens in blood by using molecular probes.

Authors:  H Einsele; H Hebart; G Roller; J Löffler; I Rothenhofer; C A Müller; R A Bowden; J van Burik; D Engelhard; L Kanz; U Schumacher
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

Review 7.  Infection in the bone marrow transplant recipient and role of the microbiology laboratory in clinical transplantation.

Authors:  M T LaRocco; S J Burgert
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

8.  Safety, tolerance, and pharmacokinetics of amphotericin B lipid complex in children with hepatosplenic candidiasis.

Authors:  T J Walsh; P Whitcomb; S Piscitelli; W D Figg; S Hill; S J Chanock; P Jarosinski; R Gupta; P A Pizzo
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

Review 9.  Chronic systemic candidiasis.

Authors:  G P Bodey; E J Anaissie
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

10.  Antifungals: need to search for a new molecular target.

Authors:  A T Sangamwar; U D Deshpande; S S Pekamwar
Journal:  Indian J Pharm Sci       Date:  2008 Jul-Aug       Impact factor: 0.975

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.